Disparities in Patients with Choroidal Melanoma between Black and Hispanic versus Non-Hispanic White Patients.

IF 1.2 Q4 OPHTHALMOLOGY
Ocular Oncology and Pathology Pub Date : 2026-09-01 Epub Date: 2026-03-23 DOI:10.1159/000551696
Charles Zhang, James K Park, Michael Y Zhao, Maura Di Nicola, Basil K Williams
{"title":"Disparities in Patients with Choroidal Melanoma between Black and Hispanic versus Non-Hispanic White Patients.","authors":"Charles Zhang, James K Park, Michael Y Zhao, Maura Di Nicola, Basil K Williams","doi":"10.1159/000551696","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Choroidal melanoma is the most common primary intraocular malignancy in adults. Early detection through ophthalmic screening increases the likelihood of globe-preserving treatment and may reduce metastasis while maximizing survival. Racial and ethnic disparities in access to care may influence outcomes, metastasis, and mortality.</p><p><strong>Methods: </strong>This retrospective cohort study used data from 2004 to 2025 within a federated electronic health record database. Adult patients (≥18 years) with choroidal melanoma were identified. Race/ethnicity was categorized as non-Hispanic white (NHW) or Black/Hispanic. The primary outcomes were primary enucleation, development of liver metastasis, and all-cause mortality within 1, 3, or 5 years from the time of choroidal melanoma diagnosis. Propensity score matching (PSM) was performed to balance cohorts. Multivariate Cox proportional hazards models were used to identify factors associated with enucleation, metastasis, and mortality.</p><p><strong>Results: </strong>A total of 17,436 patients with choroidal melanoma were identified, of whom 659 (6.3%) were Black/Hispanic and 9,883 (93.7%) were NHW. After PSM, primary enucleation within 90 days of diagnosis occurred in 5.2% of Black/Hispanic patients versus 3.8% of NHW patients (risk ratio [RR] 1.36, 95% confidence interval [CI] 0.821-2.253, <i>p</i> = 0.2305). Cumulative rates of liver metastasis in the Black/Hispanic group were significantly higher than NHW at 1 year (RR 2.42, CI: 1.336-4.387), 3 years (RR 1.96, CI: 1.246-3.083), and 5 years (RR 1.77, CI: 1.195-2.611) (<i>p</i> < 0.01 for each). All-cause mortality was higher in the Black/Hispanic cohort at 1 year (RR 1.96, CI: 1.212-3.163), 3 years (RR 1.75, CI: 1.249-2.453), and 5 years (RR 1.48, CI: 1.105-1.976) (<i>p</i> < 0.01 for each). On multivariate Cox analysis, male sex (hazard ratio [HR] 1.49, CI: 1.275-1.736, <i>p</i> < 0.0001) was associated with higher risk of enucleation, while a history of choroidal nevus was protective (HR 0.59, CI: 0.424-0.831, <i>p</i> = 0.0024). For metastatic risk, Black/Hispanic race/ethnicity (HR 1.54, CI: 1.242-1.904) and enucleation (HR 3.27, CI: 1.845-5.780) were associated with an increased risk, whereas prior nevus was protective (HR 0.43, CI: 0.324-0.577). All-cause mortality was elevated with older age (HR 1.03, CI: 1.021-1.031), male sex (HR 1.22, CI: 1.084-1.373), Black/Hispanic race/ethnicity (HR 1.42, CI: 1.135-1.769), metastatic liver disease (HR 7.49, CI: 6.051-9.269), among other comorbidities. Prior nevus history conferred a survival benefit (HR 0.59, CI: 0.458-0.762).</p><p><strong>Conclusion: </strong>In patients with newly diagnosed choroidal melanoma, Black/Hispanic patients had higher rates of metastatic disease and mortality. Previous history of choroidal nevus was associated with a lower risk of primary enucleation, metastatic disease, and mortality.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":" ","pages":"153-160"},"PeriodicalIF":1.2000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13263056/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Oncology and Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000551696","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/23 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Choroidal melanoma is the most common primary intraocular malignancy in adults. Early detection through ophthalmic screening increases the likelihood of globe-preserving treatment and may reduce metastasis while maximizing survival. Racial and ethnic disparities in access to care may influence outcomes, metastasis, and mortality.

Methods: This retrospective cohort study used data from 2004 to 2025 within a federated electronic health record database. Adult patients (≥18 years) with choroidal melanoma were identified. Race/ethnicity was categorized as non-Hispanic white (NHW) or Black/Hispanic. The primary outcomes were primary enucleation, development of liver metastasis, and all-cause mortality within 1, 3, or 5 years from the time of choroidal melanoma diagnosis. Propensity score matching (PSM) was performed to balance cohorts. Multivariate Cox proportional hazards models were used to identify factors associated with enucleation, metastasis, and mortality.

Results: A total of 17,436 patients with choroidal melanoma were identified, of whom 659 (6.3%) were Black/Hispanic and 9,883 (93.7%) were NHW. After PSM, primary enucleation within 90 days of diagnosis occurred in 5.2% of Black/Hispanic patients versus 3.8% of NHW patients (risk ratio [RR] 1.36, 95% confidence interval [CI] 0.821-2.253, p = 0.2305). Cumulative rates of liver metastasis in the Black/Hispanic group were significantly higher than NHW at 1 year (RR 2.42, CI: 1.336-4.387), 3 years (RR 1.96, CI: 1.246-3.083), and 5 years (RR 1.77, CI: 1.195-2.611) (p < 0.01 for each). All-cause mortality was higher in the Black/Hispanic cohort at 1 year (RR 1.96, CI: 1.212-3.163), 3 years (RR 1.75, CI: 1.249-2.453), and 5 years (RR 1.48, CI: 1.105-1.976) (p < 0.01 for each). On multivariate Cox analysis, male sex (hazard ratio [HR] 1.49, CI: 1.275-1.736, p < 0.0001) was associated with higher risk of enucleation, while a history of choroidal nevus was protective (HR 0.59, CI: 0.424-0.831, p = 0.0024). For metastatic risk, Black/Hispanic race/ethnicity (HR 1.54, CI: 1.242-1.904) and enucleation (HR 3.27, CI: 1.845-5.780) were associated with an increased risk, whereas prior nevus was protective (HR 0.43, CI: 0.324-0.577). All-cause mortality was elevated with older age (HR 1.03, CI: 1.021-1.031), male sex (HR 1.22, CI: 1.084-1.373), Black/Hispanic race/ethnicity (HR 1.42, CI: 1.135-1.769), metastatic liver disease (HR 7.49, CI: 6.051-9.269), among other comorbidities. Prior nevus history conferred a survival benefit (HR 0.59, CI: 0.458-0.762).

Conclusion: In patients with newly diagnosed choroidal melanoma, Black/Hispanic patients had higher rates of metastatic disease and mortality. Previous history of choroidal nevus was associated with a lower risk of primary enucleation, metastatic disease, and mortality.

黑人和西班牙裔与非西班牙裔白人脉络膜黑色素瘤患者的差异。
简介:脉络膜黑色素瘤是成人最常见的原发性眼内恶性肿瘤。通过眼科筛查的早期发现增加了保全治疗的可能性,并可能减少转移,同时最大限度地提高生存率。种族和民族在获得护理方面的差异可能会影响结果、转移和死亡率。方法:本回顾性队列研究使用联邦电子健康记录数据库中2004年至2025年的数据。成人脉络膜黑色素瘤患者(≥18岁)被确定。种族/民族分为非西班牙裔白人(NHW)或黑人/西班牙裔。主要结局是原发性去核,肝转移的发展,以及在脉络膜黑色素瘤诊断后1、3或5年内的全因死亡率。采用倾向评分匹配(PSM)来平衡队列。多变量Cox比例风险模型用于确定与去核、转移和死亡率相关的因素。结果:共发现脉络膜黑色素瘤患者17,436例,其中黑人/西班牙裔患者659例(6.3%),非裔美国人9,883例(93.7%)。PSM后,诊断后90天内发生原发性去核的黑人/西班牙裔患者为5.2%,非白人白人患者为3.8%(风险比[RR] 1.36, 95%可信区间[CI] 0.821-2.253, p = 0.2305)。黑人/西班牙裔组的累积肝转移率在1年(RR 2.42, CI: 1.336-4.387)、3年(RR 1.96, CI: 1.246-3.083)和5年(RR 1.77, CI: 1.195-2.611)时均显著高于非白人组(p < 0.01)。黑人/西班牙裔队列的全因死亡率在1年(RR 1.96, CI: 1.212-3.163)、3年(RR 1.75, CI: 1.249-2.453)和5年(RR 1.48, CI: 1.105-1.976)时均较高(p < 0.01)。多因素Cox分析显示,男性(风险比[HR] 1.49, CI: 1.277 -1.736, p < 0.0001)与较高的去核风险相关,而脉络膜痣史具有保护作用(风险比[HR] 0.59, CI: 0.424-0.831, p = 0.0024)。对于转移风险,黑人/西班牙裔种族/民族(HR 1.54, CI: 1.242-1.904)和去核(HR 3.27, CI: 1.845-5.780)与风险增加相关,而既往痣具有保护作用(HR 0.43, CI: 0.324-0.577)。全因死亡率随年龄(HR 1.03, CI: 1.021-1.031)、男性(HR 1.22, CI: 1.084-1.373)、黑人/西班牙裔种族/民族(HR 1.42, CI: 1.135-1.769)、转移性肝病(HR 7.49, CI: 6.051-9.269)以及其他合共病而升高。既往的痣史赋予生存优势(HR 0.59, CI: 0.458-0.762)。结论:在新诊断的脉络膜黑色素瘤患者中,黑人/西班牙裔患者有更高的转移率和死亡率。脉络膜痣的既往病史与原发性去核、转移性疾病和死亡率较低的风险相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
20
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书